SCHEMBL2179243

SCHEMBL2179243

CCN(CC)CCCN1CCN(CC(=O)Nc2cc(-c3ccnc(NC)n3)cc3ccc(OC)cc23)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC6 Q9UBN7 2/20 0.41
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
EGFR P00533 1/20 0.37
KCNA5 P22460 1/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
HIF1A Q16665 1/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ALDH1A1 P00352 4/20 0.36
POLB P06746 1/20 0.36
ABL1 P00519 1/20 0.36
BCR P11274 1/20 0.36
ESR1 P03372 2/20 0.36
PDGFRB P09619 2/20 0.36
KDR P35968 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2180190 0.93 JAK2 (0.42) JAK2HDAC1HDAC6KMT2AMEN1
SCHEMBL2180042 0.90 JAK2 (0.42) JAK2HDAC1HDAC6KMT2AMEN1
SCHEMBL2176488 0.89 KMT2A (0.40) JAK2HDAC1HDAC6KMT2AMEN1
SCHEMBL2178573 0.89 TP53 (0.45) JAK2HDAC1HDAC6KMT2AMEN1
SCHEMBL2184977 0.89 KDR (0.42) JAK2HDAC1HDAC6KMT2AMEN1
SCHEMBL2181105 0.88 MAPK13 (0.46) KMT2AKDM4EHPGDALDH1A1ABL1
SCHEMBL2180895 0.88 KCNA5 (0.43) JAK2HDAC1HDAC6KMT2AMEN1
SCHEMBL2181492 0.87 KMT2A (0.46) KMT2AKDM4EHPGDALDH1A1ABL1
SCHEMBL2176862 0.87 KCNA5 (0.41) JAK2HDAC1HDAC6KMT2AMEN1
SCHEMBL2179087 0.86 KMT2A (0.42) JAK2HDAC1HDAC6KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US claimed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP JAK2 321/4885HDAC1 1583/4885HDAC6 1344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.